Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:02 AM
Ignite Modification Date:
2025-12-25 @ 4:02 AM
NCT ID:
NCT03778502
Eligibility Criteria:
Inclusion Criteria:
* Objective diagnosis of venous thrombosis not involving the upper limbs, lower limbs and pulmonary arteries
* Treatment with one of the DOAC (e.g. apixaban, dabigatran, edoxaban, rivaroxaban)
Exclusion Criteria:
• Enrolment in interventional studies evaluating the DOAC for the treatment of unusual site VTE
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03778502
Study Brief:
Protocol Section:
NCT03778502